Patent · US Active

Piperidinone carboxamide azaindane CGRP receptor antagonists

US8912210B2 · kind B2 · utility

17Cited by

0References

11Claims

0Family size

Assignee

Merck Sharp & Dohme LLC · US

Inventors

Ian M. Bell · Harleysville, US
Mark E. Fraley · North Wales, US
Steven N. Gallicchio · Horsham, US
Anthony Ginnetti · Perkasie, US
Helen J. Mitchell · Richboro, US
Daniel V. Paone · Lansdale, US
Donnette D. Staas · Harleysville, US
Cheng Wang · Fort Washington, US
C. Blair Zartman · Hatfield, US

Key dates

Filing date	Nov 10, 2011
Grant date	Dec 16, 2014
Priority date	—
Expiry date	Nov 10, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to piperidinone carboxamide azaindane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.